https://www.selleckchem.com/products/ziprasidone.html Background Multivariable prediction models combine patient data points to provide actionable estimates of outcomes. Prediction models for melanoma are important for guidance in the midst of the rising incidence and evolving treatment options. This study evaluates the quality of reporting of prediction models using the Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis or Diagnosis (TRIPOD) checklist. Methods We performed a systematic literature search to identify publications describing development and/or validation of melanoma prediction models. For each study, reviewers assessed compliance with 22 TRIPOD items. We also assessed a model's predictive ability (area under the curve) compared with TRIPOD adherence. Results We originally identified 67 articles, of which 27 met inclusion criteria. No study completely followed the TRIPOD checklist, and median overall adherence was 61%. Authors were least likely to report participant characteristics, title, and abstract in accordance with the TRIPOD checklist. Linear correlation between a model's area under the curve and TRIPOD checklist adherence was not statistically significant, r = -0.09 (P = .34). Conclusion Current reporting of melanoma multivariable prediction models does not meet standards. Although there is room for improvement in how melanoma models are reported, our findings do not indicate a significant relationship between the model's performance and adherence to the TRIPOD checklist.Neurogenic tumors represent a broad ill-defined category of neoplasms that includes tumors of Schwann cell and/or neuroblastic derivation, as well as neoplasms that typically develop in the central nervous system, but rarely present in ectopic sites including the mediastinum. Neurogenic tumors may occur at many different anatomic sites, but the mediastinum represents a uniquely challenging site given the complex anatomy. Additionally, some of the